about
Current status of non-viral gene therapy for CNS disorders.In vivo multimodal magnetic particle imaging (MPI) with tailored magneto/optical contrast agentsVariation of Magnetic Particle Imaging Tracer Performance With Amplitude and Frequency of the Applied Magnetic Field.Coupling of transient near infrared photonic with magnetic nanoparticle for potential dissipation-free biomedical application in brainLactoferrin conjugated iron oxide nanoparticles for targeting brain glioma cells in magnetic particle imaging.Hyperthermia Using Antibody-Conjugated Magnetic Nanoparticles and Its Enhanced Effect with Cryptotanshinone.Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS.Recent trends on hydrogel based drug delivery systems for infectious diseasesDevelopment of magneto-plasmonic nanoparticles for multimodal image-guided therapy to the brain.Hybrid magneto-plasmonic liposomes for multimodal image-guided and brain-targeted HIV treatment.Tomographic magnetic particle imaging of cancer targeted nanoparticles.Extreme sensitive metasensor for targeted biomarkers identification using colloidal nanoparticles-integrated plasmonic unit cells.Multifunctional Nanotherapeutics for the Treatment of neuroAIDS in Drug AbusersLiving-cell imaging using a photonic crystal nanolaser arrayPleiotropic functions of magnetic nanoparticles for ex vivo gene transferSurface-engineered multimodal magnetic nanoparticles to manage CNS diseasesDynamic magnetic characterization and magnetic particle imaging enhancement of magnetic-gold core-shell nanoparticles
P50
Q33824159-3D9E2B76-AC99-49A1-8DB3-A75186566D79Q35232459-D9BE4335-413E-47DD-910D-888DFDC25016Q35646374-83B74646-D926-4F2C-90AE-01F5DE3550EDQ36087856-D05BB6AD-DDF0-430C-93FD-F5EF7529878BQ36225967-2663E4B0-8F19-49D4-B2E9-859D861EA2FDQ37638506-32AC5895-9FF8-4A0A-86AE-9DE17B3017FCQ38687781-5410A8C5-D8AB-4736-8EE2-EFFF121972E6Q38810357-7D833965-D38F-40B2-8EF9-9EF789A411C6Q43590254-178710C6-D50D-4939-BF64-958C702BD95BQ47568994-46F81F21-CD01-40BB-96DB-F1BED6A946C6Q47955292-80687492-9BBF-47C2-B051-3EFA89E3E284Q52725825-C630F6EC-571D-4B43-A8CB-0CDFAB391EA5Q56777442-6DC32CE3-5503-4DAC-9553-3DED51A7EEF9Q85631495-EB06AB55-A2B5-4A2C-9ECB-C0A682B7B2CAQ87630434-37E9BBC1-6BBF-448F-B05B-FB08552E7B88Q91124639-AA8FA6FC-77C8-46E2-BEA6-480EC761E6A9Q92498221-A880CAB2-C56D-43F6-9BA9-A6329229BB70
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Asahi Tomitaka
@ast
Asahi Tomitaka
@en
Asahi Tomitaka
@es
Asahi Tomitaka
@nl
type
label
Asahi Tomitaka
@ast
Asahi Tomitaka
@en
Asahi Tomitaka
@es
Asahi Tomitaka
@nl
prefLabel
Asahi Tomitaka
@ast
Asahi Tomitaka
@en
Asahi Tomitaka
@es
Asahi Tomitaka
@nl
P108
P106
P2038
Asahi_Tomitaka
P31
P496
0000-0002-1234-6047
P569
2000-01-01T00:00:00Z